Stock Comparison
ELAN vs TAK
Elanco Animal Health and Takeda Pharmaceutical Co Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$12.27B
$50.27B
P/E (TTM)
—
—
Forward P/E
19.3
10.3
Price/Sales
2.5
0.0
Price/Book
1.9
1.1
EV/EBITDA
21.7
16.9
Dividend Yield
—
4.16%
Profitability
Net Margin
-4.95%
-3.38%
Operating Margin
12.30%
11.10%
Return on Equity
-3.77%
-2.12%
Return on Assets
1.47%
2.55%
Growth (YoY)
Revenue Growth
14.90%
3.90%
Earnings Growth
-15.40%
330.20%
Price & Risk
Beta
1.7
0.1
52-Week High
$27.72
$18.90
52-Week Low
$13.39
$12.78
Analyst Target
$29.86
$20.60
Compare ELAN and TAK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.